Navigation Links
FDA Approves ULORIC(R) (febuxostat) for the Chronic Management of Hyperuricemia in Patients with Gout
Date:2/13/2009

First new treatment option in more than 40 years, marking second FDA approval for Takeda within one month

DEERFIELD, Ill., and OSAKA, Japan, Feb. 13 /PRNewswire/ -- Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals North America, Inc., announced today that the United States Food and Drug Administration (FDA) has approved ULORIC(R) (febuxostat) 40 mg and 80 mg for the chronic management of hyperuricemia in patients with gout. This once-daily, oral medication is the first new treatment option in more than 40 years for the more than five million patients who have hyperuricemia associated with gout. ULORIC was discovered by Teijin Pharma Limited (Teijin Pharma) of Tokyo and licensed to Takeda for the U.S. market.

"The approval of ULORIC offers clinicians and their patients who have hyperuricemia associated with gout a new treatment option that helps prevent uric acid production," said Nancy Joseph-Ridge, M.D., president, Takeda Global Research & Development Center, Inc., U.S. "In the years that we've dedicated to studying patients who have gout, I know that many patients go to their doctor during a flare not understanding that gout is a chronic disease that needs to be managed on a long-term, daily basis."

Experts recognize that a goal in the treatment of chronic gout is the reduction and maintenance of serum uric acid levels of less than 6 mg/dL. ULORIC, a xanthine oxidase inhibitor, effectively lowers levels of serum uric acid in patients with hyperuricemia associated with gout. It was studied and evaluated in multiple clinical trials involving more than 4,000 subjects, in some for up to five years.

The largest, pivotal, phase 3 clinical trial, CONFIRMS, demonstrated that ULORIC 80 mg was superior to ULORIC 40 mg and allopurinol 300/200 mg (67 percent, 45 percent and 42 percent, respectively) at achieving the primary end point of serum uric acid
'/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. FDA Approves Clinical Studies of a Novel Anti-Cancer Drug Developed by Italian Researchers
2. FDA Approves KAPIDEX(TM) (Dexlansoprazole) delayed release capsules for the Treatment of GERD
3. Bion Announces PENNVEST Board Approves $7.8 Million Financing for Kreider Farms Dairy Project
4. Monsanto Board Approves 10 Percent Dividend Increase
5. FDA Approves Most Comprehensive System to Test Donated Blood for HIV, Hepatitis B & Hepatitis C
6. MultiVu Video Feed: U.S Food and Drug Administration (Fda) Approves Latisse(TM) --
7. FDA Approves Boston Scientifics Express(R) SD Renal Stent System
8. AUDIO from Medialink and GlaxoSmithKline: FDA Approves Boostrix for Adults
9. FDA Approves Boston Scientifics Apex(TM) PTCA Dilatation Catheter
10. FDA Approves Ranexa(R) for First Line Anti Anginal Use and Adds New Claims for Reduction of Ventricular Arrhythmias, Bradycardia, New Atrial Fibrillation and HbA1c
11. FDA Approves Additional Indication for Norditropin(R) for Small for Gestational Age (SGA) in Children
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... ... 2015 , ... Visual Assay was named as a finalist for the 53rd ... and services of the past year. More than 70 judges selected the finalists, including ... be announced at the 2015 R&D 100 Awards Dinner on November 13 at Caesars ...
(Date:7/24/2015)... , July 24, 2015 Ryan & ... filed in United States District Court for the Northern District ... persons or entities that purchased the common stock of Avalanche ... between July 31, 2014 and June 15, 2015, inclusive (the ... September 8, 2015, move the Court for appointment as a ...
(Date:7/24/2015)... 24, 2015  Champions Oncology (OTC-BB: CSBR), a company ... services to personalize the development and use of oncology ... operational results for the fourth quarter and fiscal year ... 2015, before market open. The company will ... day at 9:00 a.m. EDT (6:00 a.m. PDT). To ...
(Date:7/24/2015)... 2015 The global next ... 27.8 billion by 2022, growing at an estimated CAGR ... new study by Grand View Research, Inc. Development of ... result in significant reduction in cost of sequencing one ... usage rates of next generation sequencing throughout the forecast ...
Breaking Biology Technology:Visual Assay® Named Finalist in 53rd Annual R&D 100 Awards 2Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Avalanche Biotechnologies, Inc. 2Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Avalanche Biotechnologies, Inc. 3Champions Oncology to Announce Fourth Quarter Financial Results on Tuesday, July 28 2Next Generation Sequencing (NGS) Market To Reach $27.8 Billion By 2022: Grand View Research, Inc. 2Next Generation Sequencing (NGS) Market To Reach $27.8 Billion By 2022: Grand View Research, Inc. 3Next Generation Sequencing (NGS) Market To Reach $27.8 Billion By 2022: Grand View Research, Inc. 4Next Generation Sequencing (NGS) Market To Reach $27.8 Billion By 2022: Grand View Research, Inc. 5
... only one-tenth the size of a human hair, but ... the intense heat and radiation of next generation nuclear ... power-generating reactors are being designed to provide low-cost electricity, ... not have. , The Department of Energy (DoE) ...
... Research &,Instrumentation, Inc. (CRi) announces the launch of ... brightfield or,fluorescent microscope into a multispectral imaging workstation. ... as embryos,zebrafish, plants, tissue culture and microtiter plates, ... macroscope. The Nuance 2 system will be,showcased at ...
... Inc. (OTC,Bulletin Board: SCIE) announced today that Jim Dorst ... and Chief Financial Officer., Jim Hitchin the Company,s ... of,experience in public medical device, manufacturing and software firms. ... ago. With a graduate,degree in accounting, he is well ...
Cached Biology Technology:Clemson researcher studies carbon fibers for nuclear reactor safety 2CRi Announces Nuance 2, the Next-Generation Multispectral Imaging System for Brightfield and Fluorescent-Based Microscopy 2Jim Dorst Joins SpectraScience as CFO 2
(Date:6/25/2015)... 25, 2015 According to ... (Swipe & Area), Technology, Material (Optical Prism, Piezoelectric, ... Security & Others) & Geography - Global Forecast ... said market is expected to reach $14,500.07 Million ... Browse 76 market Tables and 109 ...
(Date:6/24/2015)... 2015 This report provides market analysis of ... years. It contains an analysis of the drivers, challenges, ... impact from the short, medium, and long term perspective ... market, and technology trends that currently, prevail in the ... authorities to efficiently manage the increasing marine traffic and ...
(Date:6/23/2015)... 23, 2015   MedNet Solutions , an ... entire spectrum of clinical research, is pleased to ... , the company,s intuitive, flexible and affordable cloud-based ... 2015 Stevie® Award by the American Business ... Website category.  The American Business Awards are considered ...
Breaking Biology News(10 mins):Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4Automatic Identification System Market by Class, by Platform, by Application and by Geography - Global Forecasts & Analysis to 2014 - 2020 2MedNet Solutions' iMedNet eClinical Wins Silver Stevie Award 2
... Thanks to a single-molecule imaging technique developed by ... mechanisms of an important DNA-regulating enzyme. Helicase enzymes ... have many other functions for DNA repair and maintenance. ... called PcrA involved in preventing unwanted recombination. A ...
... lipids and carbohydrates during exercise. The carbohydrates consist of ... glucose extracted from the blood. Being a major sink ... tissue for studying the intracellular signaling pathways leading to ... it is known that the contraction-induced signaling to stimulate ...
... University School of Medicine (BUSM) report that physicians who use ... on patients with an abnormal Pap test could increase the ... achieve resolution in less time than using traditional methods. These ... . Screening for cervical cancer with a Pap ...
Cached Biology News:Researchers advance understanding of enzyme that regulates DNA 2New molecular signaling cascade increases glucose uptake 2Electronic tracking system can improve follow-up after an abnormal Pap test 2
... Detergent Clean-up Micro Kit provides a fast and ... Triton X-100 and other detergents from small samples ... Norgens patented protein resin as an ion exchanger. ... g of either acidic or basic protein.A complete ...
Compound(s) screened through any number of client selected assays. Client also selects number of concentrations and replicates....
... cells form from a hematopoietic stem cells ... to the bone surface and lowering the ... around 4.5. The bone mineral is then ... and function is controlled primarily by Macrophage ...
Values of steady state parameters for enzyme activities are determined....
Biology Products: